AGP Executive Report
Last update: 7 hours agoPharma Regulation: India’s CDSCO clarified how modified- and sustained-release drug intermediates can be licensed—new drugs need marketing permission, while certain granules may go through state licensing, with extra rules for novel excipients. Digital Health & Marketing: TRUE Addiction and Behavioral Health partnered with Web Logix Group to expand access using an AI-powered healthcare growth platform. Public Health Access: Telangana’s revamped Employees Health Scheme launches July 15, with new operational guidelines, updated hospital/package planning, and a change to how contributions are deducted for dual-employee couples. Clinical Innovation: FDA approved Viridian Therapeutics’ Lumvoa (veligrotug-vvze) for thyroid eye disease across active and chronic stages, backed by two phase 3 trials. Care Delivery: Lumbini Province Hospital introduced emergency triage labels (red/yellow/green) to speed treatment for critical cases amid high daily patient volumes. Patient Safety Tech: A fast 13-second eye test using late pupillary response may help predict consciousness recovery after severe brain injury. Medication Safety in Heat: UKHSA warned that common drugs—including diuretics, beta-blockers, and SSRIs—can raise heat illness risk. Lifestyle & Weight: A study argues diet matters more than exercise for weight loss, and another highlights that under-50s show faster biological ageing tied to rising early cancers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[NeurologyLive® Brain Games: June 28, 2026]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/25191217-913301450-a97927373a8c7c0232713cbd91884895987754a7-630x355-100x56.png)
